Fred Alger Management, LLC Amarin Corp Plcuk Transaction History

Fred Alger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $262,080 - $558,720	-72,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $38,240 - $66,080	-8,000 Reduced 10.0%	72,000 $498,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $20,000 - $107,650	-5,000 Reduced 5.88%	80,000 $320,000
Q1 2019 May 14, 2019	BUY	$12.61 - $22.33 $189,150 - $334,950	15,000 Added 21.43%	85,000 $1.77 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $868,700 - $1.61 Million	70,000 New	70,000 $953,000

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.